|
| Status |
Public on Jun 12, 2020 |
| Title |
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Methylation profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34249416 |
| Submission date |
Jun 12, 2019 |
| Last update date |
Jul 15, 2021 |
| Contact name |
Dawoon Jeong |
| E-mail(s) |
d.w.95@hanmail.net
|
| Organization name |
Dongguk University
|
| Department |
Life Science
|
| Street address |
32 Dongguk-ro, Ilsan Dong-gu
|
| City |
Goyang |
| ZIP/Postal code |
10326 |
| Country |
South Korea |
| |
|
| Platforms (3) |
| GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
| GPL21145 |
Infinium MethylationEPIC |
| GPL21185 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version] |
|
| Samples (8)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE132614 |
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [gene expression] |
| GSE132615 |
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 450K] |
| GSE132616 |
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K] |
|
| Relations |
| BioProject |
PRJNA548537 |
Less...
More...